Moderna, Inc. (MRNA) vs Regeneron Pharmaceuticals, Inc. (REGN)
A side-by-side comparison of Moderna, Inc. and Regeneron Pharmaceuticals, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of August 20, 2026. Differences are shown without an overall score or investment verdict.
MRNA
Moderna, Inc.
$174.38HealthcareAt close: Aug 19, 2026, 4:00 PM ET
REGN
Regeneron Pharmaceuticals, Inc.
$840.84HealthcareAt close: Aug 19, 2026, 4:00 PM ET
Total return — MRNA vs REGN
growth of $100 · dividends reinvested · last 8yMRNA +837.5% (+32.3%/yr)REGN +133.4% (+11.2%/yr)MRNA compounded faster over this window
MRNA REGN
MRNA vs REGN: by the numbers
- •REGN is the larger company ($86.63B vs $69.19B market cap).
- •REGN is profitable (27.86% net margin) while MRNA runs a net loss (-141.43%).
- •MRNA grew revenue faster over the past five years (19.33% vs 4.64% CAGR).
- •REGN pays a dividend (0.43% yield), while MRNA has no payments in the available dividend history.
Metrics side by side
Valuation
| Metric | MRNA | REGN |
|---|---|---|
| P/E ratio | N/A | 20.80 |
| Forward P/E | N/A | 15.97 |
| P/S ratio | 30.99 | 5.78 |
| P/B ratio | 10.21 | 2.83 |
| EV / EBITDA | N/A | 19.86 |
| FCF yield | N/A | 3.92% |
Profitability
| Metric | MRNA | REGN |
|---|---|---|
| Gross margin | 55.35% | 84.86% |
| Operating margin | -158.13% | 25.56% |
| Net margin | -141.43% | 27.86% |
| ROE | -46.61% | 13.65% |
| ROIC | -39.16% | 9.19% |
Dividends
| Metric | MRNA | REGN |
|---|---|---|
| Dividend yield | N/A | 0.43% |
| Payout ratio | N/A | 8.45% |
Growth (annualized)
| Metric | MRNA | REGN |
|---|---|---|
| Revenue CAGR (5Y) | 19.33% | 4.64% |
| EPS CAGR (5Y) | N/A | 5.70% |
| FCF CAGR (5Y) | N/A | 15.77% |
| Total return CAGR (5Y) | -14.22% | 5.30% |
Frequently asked
- Which has grown faster, MRNA or REGN?
- Over the past five years, MRNA grew revenue faster — MRNA at a 19.33% CAGR versus REGN at 4.64%.
- Does MRNA or REGN pay a bigger dividend?
- REGN pays a dividend (0.43% yield), while MRNA has no payments in the available dividend history.
- Is MRNA or REGN more profitable?
- REGN runs the higher net margin — MRNA at -141.43% versus REGN at 27.86%.
- How have MRNA and REGN total returns compared?
- Over the past 5 years, MRNA delivered -14.22% and REGN delivered 7.70% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Regeneron Pharmaceuticals P/E ratioRegeneron Pharmaceuticals dividend yieldModerna ROERegeneron Pharmaceuticals ROEModerna operating marginRegeneron Pharmaceuticals operating marginModerna revenue growthRegeneron Pharmaceuticals revenue growthModerna free cash flowRegeneron Pharmaceuticals free cash flow
Moderna & Regeneron Pharmaceuticals appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified August 20, 2026.